Literature DB >> 17133600

Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients.

Ji-Yih Chen1, Chin Man Wang, Chung-Chun Ma, Shue-Fen Luo, Jeffrey C Edberg, Robert P Kimberly, Jianming Wu.   

Abstract

OBJECTIVE: To investigate the possible association of the Fcgamma receptor IIb (FcgammaRIIb) Ile/Thr187 transmembrane domain polymorphism, which significantly affects receptor signaling, with susceptibility to systemic lupus erythematosus (SLE) in Taiwanese patients.
METHODS: We used matrix-assisted laser desorption ionization-time-of-flight mass spectrometry to genotype 351 Taiwanese SLE patients and 372 age- and sex-matched healthy individuals from the same geographic area. Allele frequencies and genotype distributions were compared between the patients and controls, both as an aggregate and as stratified by sex, autoantibody profile, and clinical parameters. A combined analysis was conducted to assess the FCGR2B Thr187 allele as a common risk factor in different ethnic populations.
RESULTS: The minor Thr187 allele was significantly associated with SLE in Taiwanese subjects (P = 0.017, odds ratio [OR] 1.989 [95% confidence interval (95% CI) 1.119-3.553]). Interestingly, male SLE patients showed enrichment of the Thr/Thr187 genotype (24%; 7 of 29) as compared with female SLE patients (10%; 32 of 322) (P = 0.043, OR 2.884 [95% CI 1.028-7.839]). Additionally, SLE patients with Thr/Thr187 and Ile/Thr187 genotypes were more likely to have pleural effusions (P = 0.038, OR 1.874 [95% CI 1.033-3.411]) and anti-SSA/Ro antibody production (P = 0.046, OR 2.221 [95% CI 1.013-4.897]). Combined analysis of 4 groups of Asian patients strongly supported the association of the FCGR2B Thr187 allele with the lupus phenotype (P = 0.000159).
CONCLUSION: The FcgammaRIIb transmembrane polymorphism is a strong disease susceptibility candidate in epistasis with other genetic effects in Taiwanese and other Asian populations. It may also play a more prominent role in male patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133600     DOI: 10.1002/art.22220

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

Review 1.  Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases.

Authors:  Sun Jung Kim
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 2.  Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Authors:  S Bournazos; J M Woof; S P Hart; I Dransfield
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

3.  The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis.

Authors:  Stefanie Meister; Robby Engelmann; Christian Kneitz; Brigitte Müller-Hilke
Journal:  Rheumatol Int       Date:  2015-01-29       Impact factor: 2.631

4.  CD19 and CD32b differentially regulate human B cell responsiveness.

Authors:  Jodi L Karnell; Nazzareno Dimasi; Fredrick G Karnell; Ryan Fleming; Ellen Kuta; Mildred Wilson; Herren Wu; Changshou Gao; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

5.  A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus.

Authors:  Lisa C Willcocks; Edward J Carr; Heather A Niederer; Tim F Rayner; Thomas N Williams; Wanling Yang; J Anthony G Scott; Britta C Urban; Norbert Peshu; Timothy J Vyse; Yu Lung Lau; Paul A Lyons; Kenneth G C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

6.  Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele.

Authors:  Su Hwa Jang; Helen Chen; Peter K Gregersen; Betty Diamond; Sun Jung Kim
Journal:  JCI Insight       Date:  2017-01-12

7.  Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans.

Authors:  Chaoling Dong; Travis S Ptacek; David T Redden; Kui Zhang; Elizabeth E Brown; Jeffrey C Edberg; Gerald McGwin; Graciela S Alarcón; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Michelle Petri; Aijian Qin; Jianming Wu; Robert P Kimberly
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

8.  Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables.

Authors:  Jorge Ramón Padilla-Gutiérrez; Claudia Azucena Palafox-Sánchez; Yeminia Valle; Gerardo Orozco-Barocio; Edith Oregón-Romero; Mónica Vázquez-Del Mercado; Héctor Rangel-Villalobos; Mara Anaís Llamas-Covarrubias; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2010-06-22       Impact factor: 3.984

9.  Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.

Authors:  Jerrard M Hayes; Asa Frostell; Robert Karlsson; Steffen Müller; Silvia Míllan Martín; Martin Pauers; Franziska Reuss; Eoin F Cosgrave; Cecilia Anneren; Gavin P Davey; Pauline M Rudd
Journal:  Mol Cell Proteomics       Date:  2017-06-02       Impact factor: 5.911

10.  A transmembrane polymorphism in FcgammaRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA.

Authors:  J-Y Chen; C-M Wang; C-C Ma; L-A Hsu; H-H Ho; Y-J J Wu; S-N Kuo; J Wu
Journal:  Genes Immun       Date:  2008-07-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.